Similar Articles
1111 Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
1112 Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
1113 Management of recurrent hepatocellular carcinoma after liver transplant
1114 Type 2 diabetes among Asian Americans: Prevalence and prevention
1115 Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization
1116 Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy
1117 Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence
1118 Therapeutic and prevention strategies against human enterovirus 71 infection
1119 Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment
1120 Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA